Literature DB >> 23636926

Diagnostic screening identifies a wide range of mutations involving the SHOX gene, including a common 47.5 kb deletion 160 kb downstream with a variable phenotypic effect.

David J Bunyan1, Kevin R Baker, John F Harvey, N Simon Thomas.   

Abstract

Léri-Weill dyschondrosteosis (LWD) results from heterozygous mutations of the SHOX gene, with homozygosity or compound heterozygosity resulting in the more severe form, Langer mesomelic dysplasia (LMD). These mutations typically take the form of whole or partial gene deletions, point mutations within the coding sequence, or large (>100 kb) 3' deletions of downstream regulatory elements. We have analyzed the coding sequence of the SHOX gene and its downstream regulatory regions in a cohort of 377 individuals referred with symptoms of LWD, LMD or short stature. A causative mutation was identified in 68% of the probands with LWD or LMD (91/134). In addition, a 47.5 kb deletion was found 160 kb downstream of the SHOX gene in 17 of the 377 patients (12% of the LWD referrals, 4.5% of all referrals). In 14 of these 17 patients, this was the only potentially causative abnormality detected (13 had symptoms consistent with LWD and one had short stature only), but the other three 47.5 kb deletions were found in patients with an additional causative SHOX mutation (with symptoms of LWD rather than LMD). Parental samples were available on 14/17 of these families, and analysis of these showed a more variable phenotype ranging from apparently unaffected to LWD. Breakpoint sequence analysis has shown that the 47.5 kb deletion is identical in all 17 patients, most likely due to an ancient founder mutation rather than recurrence. This deletion was not seen in 471 normal controls (P<0.0001), providing further evidence for a phenotypic effect, albeit one with variable penetration.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23636926     DOI: 10.1002/ajmg.a.35919

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  13 in total

1.  Growth and development. Bone dysplasia--a frequent cause of short stature in children.

Authors:  Michael B Ranke
Journal:  Nat Rev Endocrinol       Date:  2014-04-08       Impact factor: 43.330

Review 2.  Identification of 15 novel partial SHOX deletions and 13 partial duplications, and a review of the literature reveals intron 3 to be a hotspot region.

Authors:  Sara Benito-Sanz; Alberta Belinchon-Martínez; Miriam Aza-Carmona; Carolina de la Torre; Celine Huber; Isabel González-Casado; Judith L Ross; N Simon Thomas; Andrew R Zinn; Valerie Cormier-Daire; Karen E Heath
Journal:  J Hum Genet       Date:  2016-09-08       Impact factor: 3.172

3.  Systematic molecular analyses of SHOX in Japanese patients with idiopathic short stature and Leri-Weill dyschondrosteosis.

Authors:  Hirohito Shima; Toshiaki Tanaka; Tsutomu Kamimaki; Sumito Dateki; Koji Muroya; Reiko Horikawa; Junko Kanno; Masanori Adachi; Yasuhiro Naiki; Hiroyuki Tanaka; Hiroyo Mabe; Hideaki Yagasaki; Shigeo Kure; Yoichi Matsubara; Toshihiro Tajima; Kenichi Kashimada; Tomohiro Ishii; Yumi Asakura; Ikuma Fujiwara; Shun Soneda; Keisuke Nagasaki; Takashi Hamajima; Susumu Kanzaki; Tomoko Jinno; Tsutomu Ogata; Maki Fukami
Journal:  J Hum Genet       Date:  2016-03-17       Impact factor: 3.172

4.  SHOX Deficiency in Argentinean Cohort: Long-Term Auxological Follow-Up and a Family's New Mutation.

Authors:  Mariana Del Pino; Miriam Aza-Carmona; David Medino-Martín; Abel Gomez; Karen E Heath; Virginia Fano; María Gabriela Obregon
Journal:  J Pediatr Genet       Date:  2019-05-28

Review 5.  SHOX Haploinsufficiency as a Cause of Syndromic and Nonsyndromic Short Stature.

Authors:  Maki Fukami; Atsuhito Seki; Tsutomu Ogata
Journal:  Mol Syndromol       Date:  2016-03-15

6.  SHOX haploinsufficiency presenting with isolated short long bones in the second and third trimester.

Authors:  Shwetha Ramachandrappa; Abhijit Kulkarni; Hina Gandhi; Cheryl Ellis; Renata Hutt; Lesley Roberts; Rosol Hamid; Aris Papageorghiou; Sahar Mansour
Journal:  Eur J Hum Genet       Date:  2018-01-12       Impact factor: 4.246

Review 7.  A Track Record on SHOX: From Basic Research to Complex Models and Therapy.

Authors:  Antonio Marchini; Tsutomu Ogata; Gudrun A Rappold
Journal:  Endocr Rev       Date:  2016-06-29       Impact factor: 19.871

8.  Retinoic acid catabolizing enzyme CYP26C1 is a genetic modifier in SHOX deficiency.

Authors:  Antonino Montalbano; Lonny Juergensen; Ralph Roeth; Birgit Weiss; Maki Fukami; Susanne Fricke-Otto; Gerhard Binder; Tsutomu Ogata; Eva Decker; Gudrun Nuernberg; David Hassel; Gudrun A Rappold
Journal:  EMBO Mol Med       Date:  2016-12-01       Impact factor: 12.137

9.  Microarray testing in clinical diagnosis: an analysis of 5,300 New Zealand patients.

Authors:  Adrian Mc Cormack; Karen Claxton; Fern Ashton; Philip Asquith; Edward Atack; Roberto Mazzaschi; Paula Moverley; Rachel O'Connor; Methat Qorri; Karen Sheath; Donald R Love; Alice M George
Journal:  Mol Cytogenet       Date:  2016-03-31       Impact factor: 2.009

10.  Identification of a limb enhancer that is removed by pathogenic deletions downstream of the SHOX gene.

Authors:  Isabella Skuplik; Sara Benito-Sanz; Jessica M Rosin; Brent E Bobick; Karen E Heath; John Cobb
Journal:  Sci Rep       Date:  2018-09-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.